Literature DB >> 29616366

De-escalation of breast radiotherapy after conserving surgery in low-risk early breast cancer patients.

Pierfrancesco Franco1, Giuseppe Carlo Iorio2, Sara Bartoncini3, Mario Airoldi4, Corrado De Sanctis5, Isabella Castellano6, Umberto Ricardi2.   

Abstract

The reduction in the burden related to treatment is becoming more and more important in modern oncology. Radiation therapy is a mainstay option in the postoperative setting for early breast cancer patients after breast-conserving surgery. Nowadays, different options are available to de-escalate radiotherapy in this scenario such as the use of hypofractionated whole-breast radiation, the selective delivery of the boost dose to the lumpectomy cavity, the introduction of accelerated partial breast irradiation and the omission of treatment in appropriately selected patients with low-risk features. We herein provide a review article on this topic.

Entities:  

Keywords:  Accelerated partial breast irradiation; Boost; Breast cancer; De-escalation; Hypofractionation; Radiotherapy omission; Whole-breast radiation

Mesh:

Year:  2018        PMID: 29616366     DOI: 10.1007/s12032-018-1121-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  71 in total

1.  Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation.

Authors:  Paolo Rovea; Alessandra Fozza; Pierfrancesco Franco; Chiara De Colle; Alessandra Cannizzaro; Anna Di Dio; Francesca De Monte; Claudia Rosmino; Andrea Riccardo Filippi; Riccardo Ragona; Umberto Ricardi
Journal:  Clin Breast Cancer       Date:  2015-01-07       Impact factor: 3.225

2.  Intensity-modulated adjuvant whole breast radiation delivered with static angle tomotherapy (TomoDirect): a prospective case series.

Authors:  Pierfrancesco Franco; Michele Zeverino; Fernanda Migliaccio; Piera Sciacero; Domenico Cante; Valeria Casanova Borca; Paolo Torielli; Cecilia Arrichiello; Giuseppe Girelli; Gianmauro Numico; Maria Rosa La Porta; Santi Tofani; Umberto Ricardi
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-14       Impact factor: 4.553

3.  Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

Authors:  Ian H Kunkler; Linda J Williams; Wilma J L Jack; David A Cameron; J Michael Dixon
Journal:  Lancet Oncol       Date:  2015-01-28       Impact factor: 41.316

4.  Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.

Authors:  Ivo A Olivotto; Timothy J Whelan; Sameer Parpia; Do-Hoon Kim; Tanya Berrang; Pauline T Truong; Iwa Kong; Brandy Cochrane; Alan Nichol; Isabelle Roy; Isabelle Germain; Mohamed Akra; Melanie Reed; Anthony Fyles; Theresa Trotter; Francisco Perera; Wayne Beckham; Mark N Levine; Jim A Julian
Journal:  J Clin Oncol       Date:  2013-07-08       Impact factor: 44.544

5.  Hypofractionated whole-breast radiotherapy and concomitant boost after breast conservation in elderly patients.

Authors:  Domenico Cante; Pierfrancesco Franco; Piera Sciacero; Giuseppe Girelli; Massimo Pasquino; Valeria Casanova Borca; Santi Tofani; Maria Rosa La Porta; Umberto Ricardi
Journal:  Tumori       Date:  2015-08-26       Impact factor: 2.098

6.  Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial.

Authors:  John Yarnold; Anita Ashton; Judith Bliss; Janis Homewood; Caroline Harper; Jane Hanson; Jo Haviland; Søren Bentzen; Roger Owen
Journal:  Radiother Oncol       Date:  2005-03-16       Impact factor: 6.280

7.  Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.

Authors:  R W Blamey; T Bates; U Chetty; S W Duffy; I O Ellis; D George; E Mallon; M J Mitchell; I Monypenny; D A L Morgan; R D Macmillan; J Patnick; S E Pinder
Journal:  Eur J Cancer       Date:  2013-03-21       Impact factor: 9.162

8.  Simultaneous integrated boost for adjuvant treatment of breast cancer--intensity modulated vs. conventional radiotherapy: the IMRT-MC2 trial.

Authors:  Vasileios Askoxylakis; Alexandra D Jensen; Matthias F Häfner; Leonie Fetzner; Florian Sterzing; Joerg Heil; Christof Sohn; Johannes Hüsing; Uta Tiefenbacher; Frederik Wenz; Jürgen Debus; Holger Hof
Journal:  BMC Cancer       Date:  2011-06-15       Impact factor: 4.430

9.  Long-term side effects and cosmetic outcome in a pool of breast cancer patients treated with intraoperative radiotherapy with electrons as sole treatment.

Authors:  Maria Cristina Leonardi; Giovanni Battista Ivaldi; Luigi Santoro; Roberta Lazzari; Annamaria Ferrari; Anna Morra; Pietro Caldarella; Loredana Burgoa; Fabio Domenico Bassi; Claudia Sangalli; Nicole Rotmensz; Alberto Luini; Umberto Veronesi; Roberto Orecchia
Journal:  Tumori       Date:  2012 May-Jun

10.  Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.

Authors:  Mitch Dowsett; Ivana Sestak; Elena Lopez-Knowles; Kalvinder Sidhu; Anita K Dunbier; J Wayne Cowens; Sean Ferree; James Storhoff; Carl Schaper; Jack Cuzick
Journal:  J Clin Oncol       Date:  2013-07-01       Impact factor: 44.544

View more
  10 in total

1.  Do hypofraction and large breast size reciprocally fit in breast cancer radiotherapy?

Authors:  Pierfrancesco Franco; Sara Bartoncini; Stefania Martini; Giuseppe Carlo Iorio; Umberto Ricardi
Journal:  Ann Transl Med       Date:  2019-07

2.  Controversial issues in radiotherapy after breast-conserving surgery for early breast cancer in older patients: a systematic review.

Authors:  Liuwei Tang; Haruo Matsushita; Keiichi Jingu
Journal:  J Radiat Res       Date:  2018-11-01       Impact factor: 2.724

3.  Breast size impact on adjuvant radiotherapy adverse effects and dose parameters in treatment planning.

Authors:  Ivica Ratosa; Aljasa Jenko; Irena Oblak
Journal:  Radiol Oncol       Date:  2018-08-02       Impact factor: 2.991

4.  Adjuvant chemotherapy for node negative, high Recurrence ScoreTM breast cancer: in defense of de-escalation.

Authors:  Diana Lake; Andrew D Seidman
Journal:  NPJ Breast Cancer       Date:  2019-08-12

Review 5.  Suggestions for Radiation Oncologists during the COVID-19 Pandemic.

Authors:  Pierfrancesco Franco; Lofti Kochbati; Marco Siano; Berardino De Bari
Journal:  Biomed Res Int       Date:  2020-05-26       Impact factor: 3.411

6.  A patient decision aid for breast cancer patients deciding on their radiation treatment, no change in decisional conflict but better informed choices.

Authors:  D B Raphael; N S Russell; B Winkens; J M Immink; P G Westhoff; M C Stenfert Kroese; M R Stam; N Bijker; C M J van Gestel; T van der Weijden; L J Boersma
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2021-08-29

7.  Hypofractionation and Concomitant Boost in Ductal Carcinoma In Situ (DCIS): Analysis of a Prospective Case Series with Long-Term Follow-Up.

Authors:  Domenico Cante; Marina Paolini; Cristina Piva; Edoardo Petrucci; Lorenzo Radici; Silvia Ferrario; Guido Mondini; Silvia Bagnera; Maria Rosa La Porta; Pierfrancesco Franco
Journal:  Life (Basel)       Date:  2022-06-14

8.  Comparison of Efficacy and Psychology of Breast-Conserving Surgery and Modified Radical Mastectomy on Patients with Early Breast Cancer under Graded Nursing.

Authors:  Tiantian Ren; Jianli Wu; Lu Qian; Jing Liu; Kan Ni
Journal:  Comput Math Methods Med       Date:  2022-09-16       Impact factor: 2.809

Review 9.  Accelerated Partial Breast Irradiation: A New Standard of Care?

Authors:  Tobias Forster; Clara Victoria Katharina Köhler; Jürgen Debus; Juliane Hörner-Rieber
Journal:  Breast Care (Basel)       Date:  2020-02-21       Impact factor: 2.860

Review 10.  Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine.

Authors:  Pierfrancesco Franco; Fiorenza De Rose; Maria Carmen De Santis; Nadia Pasinetti; Valentina Lancellotta; Bruno Meduri; Icro Meattini
Journal:  Clin Transl Radiat Oncol       Date:  2020-02-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.